Compare stocks

NanoRepro AG is a German company operating in the healthcare industry, specializing in the development and distribution of diagnostic rapid tests. The company offers a range of products primarily focused on fertility, infectious diseases, and preventive care, providing over-the-counter solutions that cater to both professional and consumer markets. Founded in 2002, NanoRepro is headquartered in Marburg, Germany. The company leverages a network of distribution partners to enhance its market presence across various countries, reflecting a strategic focus on expanding its geographical footprint. NanoRepro's competitive strength lies in its emphasis on research and development, supporting its capability to introduce innovative diagnostic solutions.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.